Guardant Health (GH) closed the last trading session at $22.66, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $47.56 indicates a 109.9% upside potential.The average comprises 16 short-term price targets ranging from a low of $27 to a high of $64, with a standard deviation of $10.63. While the lowest estimate indicates an increase of 19.2% from the current price level ...